IndexIQ Advisors’s Medtronic MDT Stock Holding History

IndexIQ Advisors’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$2.68M	Sell	24,128 -1,547	-6%	-$163K	0.09%	208
2021 Q4	$2.66M	Sell	25,675 -327	-1%	-$37.9K	0.09%	202
2021 Q3	$3.26M	Buy	26,002 +1,108	+4%	+$143K	0.11%	170
2021 Q2	$3.09M	Buy	24,894 +711	+3%	+$89.3K	0.1%	175
2021 Q1	$2.86M	Sell	24,183 -15,639	-39%	-$1.83M	0.1%	197
2020 Q4	$4.67M	Buy	39,822 +8,821	+28%	+$971K	0.17%	86
2020 Q3	$3.22M	Buy	31,001 +5,919	+24%	+$594K	0.13%	104
2020 Q2	$2.3M	Buy	25,082 +3,164	+14%	+$303K	0.1%	145
2020 Q1	$1.98M	Sell	21,918 -24,449	-53%	-$2.6M	0.09%	130
2019 Q4	$5.26M	Buy	46,367 +10,419	+29%	+$1.14M	0.19%	86
2019 Q3	$3.9M	Sell	35,948 -12,289	-25%	-$1.28M	0.14%	93
2019 Q2	$4.7M	Sell	48,237 -1,197	-2%	-$109K	0.14%	116
2019 Q1	$4.5M	Buy	+49,434	New	+$4.42M	0.13%	95

Other funds holding MDT

WestEnd Advisors Charlotte, North Carolina $4.14B AUM 15.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

IndexIQ Advisors's MDT Position: Q1 2022 in Review

IndexIQ Advisors reduced its Medtronic (MDT) stake by 6% in Q1 2022, selling an estimated $163K and leaving 24,128 shares worth $2.68M. The position accounts for 0.09% of the portfolio, ranked #208.

IndexIQ Advisors first reported a position in MDT in Q1 2019 and has held it in 13 quarters since. The position peaked at $5.26M in Q4 2019. 2,101 funds tracked by Wall St. Rank hold MDT as of Q1 2022.

IndexIQ Advisors held 24,128 shares of Medtronic worth $2.68M as of Q1 2022.
IndexIQ Advisors sold 1,547 Medtronic shares in Q1 2022, an estimated $163K.
Medtronic made up 0.09% of IndexIQ Advisors's portfolio in Q1 2022, its #208 holding.
IndexIQ Advisors first reported a position in Medtronic in Q1 2019 and has held it in 13 quarters since.
IndexIQ Advisors's Medtronic position peaked at $5.26M in Q4 2019.
2,101 funds tracked by Wall St. Rank held Medtronic as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.